BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹0.70 Cr | ₹0.60 Cr | ₹2.63 Cr | ₹3.58 Cr | ₹4.18 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹0.70 Cr |
Mar2022 | ₹0.60 Cr |
Mar2021 | ₹2.63 Cr |
Mar2020 | ₹3.58 Cr |
Mar2019 | ₹4.18 Cr |
How is Deferred Tax Assets / Liabilities of BAL PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹0.70 Cr | 16.39 | |
Mar2022 | ₹0.60 Cr | -77.05 | |
Mar2021 | ₹2.63 Cr | -26.56 | |
Mar2020 | ₹3.58 Cr | -14.26 | |
Mar2019 | ₹4.18 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹163.1 Cr | 3% | 2.7% | 22.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,470.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹112,990.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,846.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,849.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,742.1 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 3% |
2.7% |
22.9% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses